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SUMMARY. We have determined the structure of the core
capsid of an unusual variant of hepatitis B virus, genotype G
(HBV/G) at 14 A ˚ resolution, using cryo-electron microscopy.
The structure reveals surface features not present in the
prototype HBV/A genotype. HBV/G is novel in that it has a
unique 36- bp insertion downstream of the core gene start
codon. This results in a twelve amino acid insertion at the
N-terminal end of the core protein, and two stop codons in
the precore region that prevent the expression of HBeAg.
HBV/G replication in patients is associated with co-infection
with another genotype of HBV, suggesting that HBV/G may
have reduced replication efﬁciency in vivo. We localized the
N-terminal insertion in HBV/G and show that it forms two
additional masses on the core surface adjacent to each of
the dimer-spikes and have modelled the structure of the
additional residues within this density. We show that the
position of the insertion would not interfere with translo-
cation of nucleic acids through the pores to the core interior
compartment. However, the insertion may partially obscure
several residues on the core surface that are known to play a
role in envelopment and secretion of virions, or that could
affect structural rearrangements that may trigger envelop-
ment after DNA second-strand synthesis.
Keywords: core-like particles, electron microscopy, Hepatitis
B virus.
INTRODUCTION
Hepatitis B virus (HBV) is one of the most important causes
of liver disease in humans. Although HBV infection is pre-
ventable by vaccination, it currently affects more than 350
million people worldwide, with many infected as long-term
carriers [1]. HBV is a member of the Hepadnaviridae with a
partially double stranded DNA genome of 3.2 kb in size [2].
The HBV nucleocapsid core is icosahedral and enveloped by
a membrane containing the surface antigen glycoprotein
(HBsAg). At the structural level, the nucleocapsid of the
prototype HBV (genotype A) has been studied extensively by
both cryo-electron microscopy (cryo-EM) and X-ray crys-
tallography [2–4]. In addition to the presence of HBsAg, two
other diagnostic markers can frequently be detected in the
serum of infected patients: antibody directed against the core
antigen (HBcAg, consisting of assembled capsids) and the
e antigen (HBeAg) an alternate translation product of the
core gene that is cleaved and secreted posttranslationally.
The HBcAg is dimeric, and assembled cores exhibit oligo-
meric dimorphism: a proportion has T = 3 symmetry (with
180 subunits, consisting of 90 dimers of HBcAg) and the
other proportion having T = 4 symmetry (240 subunits and
120 dimers) [5]. This icosahedral dimorphism is present
both in cores that are puriﬁed from the serum of HBV-in-
fected patients and in core-like particles which self-assemble
upon in vitro expression of the core protein. When the HBV
virion enters cells, the uncoated core is transported to the
nucleus where HBV genomic DNA is repaired to the cova-
lently closed circular DNA form. During replication, the
RNA pregenome is incorporated into assembling cores, and
reverse transcription to form the genomic DNA occurs
within the assembled core [2]. The core protein dimers form
spike-like protrusions which extend from the spherical sur-
face of the core particle, and also form a network of pores or
holes [2].
The presence of different genotypes of HBV has been cor-
related with different geographical regions and with varying
severity of disease [6]. Recently, a novel genotype of HBV
(HBV/G) was described [7], which has a unique 36- bp
insertion downstream of the core gene start codon, resulting
in a twelve amino acid insertion at the N-terminal end of the
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  2010 Blackwell Publishing Ltdcore protein. In addition, HBV/G has two stop codons in the
precore region at positions 2 and 28, which prevent the
expression of HBeAg [8]. The fact that HBV/G is almost
exclusively detected in patients in association with one of the
other seven HBV genotypes (usually HBV/A), and the fre-
quent presence of HBeAg in HBV/G-infected individuals,
suggests that HBV/G replication requires co-infection with a
helper virus of another HBV genotype [9,10]. The unique
epidemiological and clinical proﬁle of HBV/G suggested that
it could be deﬁcient in some other aspects of its function,
perhaps as a result of the differences in the capsid structure
and function caused by the presence of the N-terminal
insertion in the core protein. Although HBV/G has been
shown to be capable of replication in the absence of another
co-infecting genotype in vitro, the envelopment of genotype
G appeared to be less efﬁcient than that of genotype A, while
the presence of the 36-nt insertion enhanced core protein
expression and genome replication [9]. The aim of this study
was to investigate for the ﬁrst time the structural morphol-
ogy of the HBV/G core particles in comparison with HBV/A,
and in particular to localize the 12 amino acid insertion. We
used cryo-electron microscopy and structural modelling to
investigate structural differences in the features of HBV/G
core-like particles that could inﬂuence functions such as
replication, genome packaging, or possibly HBsAg envelop-
ment of the capsid and viral secretion.
MATERIALS AND METHODS
Preparation and puriﬁcation of core protein
from HBV Genotype G
HBV/G-infected individuals were identiﬁed through routine
diagnostic testing and strain surveillance at the National
Microbiology Laboratory (NML) using sequencing and phy-
logenetic analysis [10]. The gene coding for the HBV/G core
protein was PCR ampliﬁed, cloned into the pET28b vector
(Novagen, EMD Biosciences, Gibbstown, NJ, USA) and
expressed in Escherichia coli strain BL21 (DE3). Clariﬁed
culture lysates were centrifuged on a 20–60% sucrose gra-
dient at 30 000 rpm in a Beckman SW4OTi rotor for 14 h.
Fractions were analysed by SDS–PAGE and Western blotting
with anti-HBc antibody (MA1-21697; Pierce Antibody,
Rockford, IL, USA). Cores were dialysed against PBS pH 7.4
using a 10 K MW cut off Pierce Slide-A-Lyzer cassette
(Thermo Scientiﬁc, Waltham, Massachusetts, USA). The
HBV/G core sequence was submitted to the National Center
for Biotechnology Information GenBank database under
accession number GU325783.
Cryo-EM sample preparation and data collection
Cryo-EM and specimen preparation was performed as
previously described [11,12]. Brieﬂy, specimens on glow-
discharged Quantifoil grids (Quantifoil MicroTools GmbH,
Jena, Germany) were plunge cooled in liquid ethane using a
Vitribot Mark IV (FEI Company). Specimens were imaged at
200 kV in a FEI Tecnai 20G
2 electron microscope equipped
with a 4K CCD camera (FEI Company, Hillsboro, Oregon,
USA). Images were recorded at a magniﬁcation of 80 000·,
(corresponding to 108 240· at the CCD detector, or
1.353 A ˚/pixel) using a total dose of 10 electrons/A ˚ 2 and a
defocus of 3.5–6 l. A total of 13 455 particles were analy-
sed. Correction was made for the contrast transfer function
using EMAN [13]. T = 3 or T = 4 capsids were separated in
SPIDER [14] (Fig. 1b,c). Two populations of 1887, and
11 568 images of T = 3 and T = 4 capsids, respectively,
were analysed.
Image processing
The T = 4 capsids were analysed, and class averages were
calculated for the twofold, threefold and ﬁvefold axes of
symmetry. A preliminary icosahedral 3D model was visually
inspected using the Chimera software package [15]. Data
were then analysed using projection matching [14,16]. Be-
tween each reﬁnement cycle the software package SITUS
[17] was used in parallel to select the contiguous mass
which corresponded to a single T = 4 HBV/G capsid.
Resolution, and comparison of the HBV/A
and HBV/G models
Resolution of the structure was estimated by plotting the
Fourier shell correlation (FSC) against resolution, giving a
value of 14 A ˚ at an FSC of 0.5. The resolution of the HBV/A
model 1QGT.pdb determined by X-ray crystallography [4]
was then reduced to 14 A ˚ using the EMAN program
pdb2mrc [13]. Both maps were normalized for electron
density, aligned and compared by creating a difference map.
The contour level of the difference map was selected so that
its mass matched the volume of the additional 12 residue
N-terminal insert of the HBV/G core structure [17].
The tertiary structure of the 12 residues was predicted by
the I-TASSER server [18], and the resulting coordinates were
modelled in to the difference map density HBV/G structure
using the program COOT [19].
RESULTS
Cryo-EM revealed that the HBV/G core protein was able to
form T = 3 and T = 4 capsid structures similar to those
formed by genotype A (Fig. 1). Thus, we conﬁrmed that the
additional 12 N-terminal residues do not impair capsid for-
mation. Furthermore, the insertion does not affect the basic
structure of the core, other than presenting two additional
regions of mass at the base of each of the spikes. Several
groups have previously engineered N-terminal extensions to
the HBcAg and found that this did not impair self-assembly
of the expressed proteins into core-like particles [20,21]. The
  2010 Blackwell Publishing Ltd
444 J. J. H. Cotelesage et al.majority of the HBV/G cores had T = 4 morphology, as
previously reported in expressed core–like particles, and in
cores isolated from patient specimens [22].
Superﬁcially, the three-dimensional structure of the T = 4
capsid formed by HBV/G core protein looks very similar to
the crystal structure of the HBV/A capsid, PDB accession
(a) (b)
(c)
(d)
Fig. 1 (a) Cryo-electron microscopy of
HBV/G core-like particles. T = 3
particles (white arrows) and T = 4
particles (black arrows) are shown.
Panels (b) and (c) illustrate the sorting
of the T = 3 capsids from T = 4
capsids, respectively. The rotational
average (top left in panels b and c) was
used as a reference for sorting. Several
representative sorted particles are
presented. Characteristic class averages
generated by projection matching for
the T = 4 reconstruction are shown
in (d).
(a) (b)
(d) (c)
Fig. 2 Surface shaded representation of
the HBV/A capsid structure solved by
X-ray crystallography (yellow), and
HBV/G capsid structure solved by
cryoEM (green) are shown in (a) and
(b), respectively. Structures are Fourier
ﬁltered to 14 A ˚ resolution for
comparison. A difference map
(c, shown in blue) was created by
subtracting the HBV/A capsid structure
from the HBV/G core structure is
presented with a mass threshold set to
account for the 12 extra residues from
the HBV/G cryo-EM map. Panel
(d) shows the difference map (blue)
superimposed over the HBV/A core
crystal structure (yellow). In all four
panels, a red oval has been superposed
over the reconstruction to highlight a
single dimer spike in the structures at
the base of the spike.
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Core structure of HBV genotype G 4451QGT (Figs 2a,b) [4]. The difference map created shows
additional mass around the base of the spikes of the HBV
core protomers (Figs 2c,d). When the difference map is
superimposed with the HBV/A atomic coordinates the
additional mass of the HBV/G structure is found to be
adjacent to the N-terminal residues of the core protein
(Fig. 2d and Figs 3a, b). The extra mass protrudes from the
surface of the core particle and sits beside the capsid pores
and not over them, so this feature would not effectively
reduce the diffusive movement of nucleotide triphosphates
into the core interior, or affect the release of nucleic acids
from the core (Fig. 3a, b). When modelling the extra 12
residues by TASSER/COOT, it was apparent that there are a
number of possible arrangements that 12 residues can take
up and still be contained within the corresponding density
(Fig. 3c). Previously, a crystal structure of an HBV capsid
protein engineered with an additional 11 residue extension
to its N-terminal end has been determined, PDB accession
2QIJ [21]. Although the orientation was different from that
observed in HBV/G, both additional masses were pointing
away from the four-helix bundle as opposed to interacting
with the main body of the core protein (Fig. 3c).
DISCUSSION
The possible function or role that the additional N-terminal
mass in the core protein of HBV/G may play in replication,
and the reason for its retention only in the HBV/G strain is
unclear. However, the 36-nt core insertion on HBV/G
appears to result in less efﬁcient envelopment of mature
virions compared to that of HBV/A [9].
The HBV capsid plays an important role in envelopment
of the virion with membrane containing the HBsAg, which
is a prerequisite for the secretion of viable progeny virions
[2]. Amino acids in the core protein that are involved in
envelopment competence, and which presumably make
important contacts with the cytoplasmic domain of mem-
brane-bound preS1 protein, have been mapped, both by
mutagenesis [23–25] and by analysis of naturally occur-
ring patient-derived HBV mutants that vary in their
capacities to secrete mature virions [26–28]. There are
thus 11 residues that have been shown to be essential for
envelopment but were nonessential for capsid formation. A
number of these 11 residues (shown in purple in Figs 3a, b)
are found near the electron density made by the extra
(a)
(b)
(c)
Fig. 3 (a) and (b). Stereo images of the HBV/A core protein structure. The red ribbon is the HBV/A core crystal structure, PDB
accession 1QGT, and the yellow density is the structure derived from the HBV/A core X-ray crystallography data displayed at
14 A ˚ resolution, to match resolution of the difference map shown in blue. The additional mass found on HBV/G (blue density)
was determined by subtracting the HBV/A structure from the HBV/G structure. (a) The mass from the extra 12 amino acids
on the N-terminal end of HBV/G is near to the N-terminal end of the HBV/A core (the portion of the ribbon coloured green).
(b) Top view looking down one of the spike 2-fold axes. Locations of the amino acids critical for the encapsidation of the
mature HBV particle, and that interact with the cytoplasmic domains of the HBsAg, are shown as purple spheres. The extra
mass from the 12 amino acid insert may stearically interfere with access to some of these residues (notably S17, F18, L60,
L95). (c) Side and top views of HBV/G core protein model (red ribbon) with the12 residue N-terminal insertion (yellow ribbon)
modelled into the difference map density (transparent blue). Only one copy of the core molecule within the dimer is shown for
clarity.
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446 J. J. H. Cotelesage et al.N-terminal insertion peptide of HBV/G (Fig. 3b). It is
tempting to speculate that the 12 amino acid N-terminal
insertion in HBV/G could be responsible for partially
reducing the efﬁcient envelopment of HBV/G, because of its
proximity to several of these key residues that make con-
tacts with the cytoplasmic domain of HBsAg. In particular,
the N-terminal insertion partially covers several of these
residues that were shown to be involved in secretion of
mature particles, notably S17, F18, L60 and L95 (Fig. 3b)
and thus might sterically hinder interactions between the L
protein and core particle of HBV/G during envelopment. In
addition, in previously published work, Hui et al. [20]
showed that an insertion of 23 amino acids engineered on
the N-terminal end of the HBV core protein could prevent
core envelopment by membranes containing HBsAg. The
additional N-terminal residues in HBV/G could interfere
with one or more of the essential contacts that are
important for core envelopment, leading to attenuated or
partially deﬁcient virion maturation. Our data show that
the N-terminal insertion in the core of HBV/G partially
covers the hydrophobic pocket which contains the resi-
dues that are essential for normal virion secretion [22].
This pocket has been shown to undergo structural changes
after envelopment, which may act as a trigger, to ensure
that envelopment does not take place until after DNA
second-strand synthesis has completed [22]. In HBV/G the
N-terminal insertion might therefore also interfere with
these structural changes, as well as sterically hindering key
amino acids that are thought to interact with the envelope.
A reduced ability for virion envelopment and secretion
might partially explain why the presence of HBV/G in pa-
tients is strongly associated with co-infection by another
genotype.
Our structural analysis shows that speciﬁc antibodies or
other ligands directed against the 12 amino acid insertion
would be able to readily bind without stearic hindrance.
This unique peptide that is exposed on the surface of the
HBV/G core could be exploited as a possible site for epitope
presentation in an HBcAg core–based vaccine. Because
HBV/G already has an insertion in the N-terminus, it may
tolerate even larger insertions than have been tried previ-
ously in HBV/A cores, while still maintaining the ability for
efﬁcient self-assembly. In addition, the possibility of
detecting speciﬁc antibodies directed against the insertion
peptide in sera from patients infected with HBV/G could be
explored. Such testing might help to resolve the issue of
whether HBV/G can replicate in vivo in the absence of a
helper virus strain and would assist in diagnosing patients
infected with HBV/G.
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